Novavax files for approval of its COVID booster in US

Monday, 15. August 2022 15:53

Novavax Inc. announced on Monday it has requested the authorization of its COVID-19 booster vaccine in people who have already received other approved shots in the United States. "It's important for people to have a choice as they evaluate how to stay protected against COVID-19," Chief Executive Stanley Erck noted amid the worse-than-expected vaccine rollout across the country.

Novavax's vaccine has been administered 9,700 times in the US, out of 606 million shots given so far to around two-thirds of the Americans that have been fully vaccinated. In its latest earnings report, Novavax halved its 2022 revenue forecast impaired by slow sales of its vaccine in the US.

Related Links: Novavax Inc.
Baha Breaking News (BBN) / ND